ADVOCIN™ (danofloxacin mesylate), from Pfizer Animal Health, is a cost-effective fluoroquinolone alternative for the treatment of bovine respiratory disease. Featuring a withdrawal time of just four days and a single 2 mL/100 lb. dose, ADVOCIN is part of the fluoroquinolone class of antimicrobials, which can quickly reach a high concentration at the site of infection. The short withdrawal requirement gives producers increased flexibility to treat animals during the entire feeding period. ADVOCIN is available in 250-mL bottles, or 25 treatments/bottle based on a 500-lb. animal.
For more information, visit your veterinarian, Pfizer Animal Health representative, or www.PfizerAH.com.
Gene-Max™, a product of Certified Angus Beef® (CAB®), Angus Genetics Inc., and Pfizer Animal Genomics, evaluates marbling and post-weaning gain on high-percentage Angus cattle sired by registered Angus bulls. Once DNA is collected, results return in less than four weeks in the form of GMX™score, an economically weighted score based on historical average and trends for the value contributions of gain and marbling, compared to other high-percentage Angus cattle.
For more information on the Gene-Max test, visit cabpartners.com.
BRD Shield® is a modified-live vaccine (MLV) that protects non-pregnant beef and dairy cattle against bovine respiratory disease (BRD) complex. It provides broad-spectrum protection against bovine virus diarrhea (BVD) Type 1 and 2, infectious bovine rhinotracheitis (IBR), parainfluenza 3 (PI3) and bovine respiratory syncytial virus (BRSV). The only MLV with antigens for protection against the noncytopathic (NCP) biotype of BVD Type 1 and BVD Type 2, field testing shows BRD Shield is safe for calves as young as four weeks of age, with no adverse impact on meat or carcass quality when used as directed.
For more information about BRD Shield, contact your Novartis Animal Health representative or visit www.livestock.novartis.com.
Novartis Animal Health’s NUPLURA™ PH provides fast-acting protection against bovine pneumonia caused by Mannheimia (Pasteurella) haemolytica. The only U.S. cattle vaccine developed with recombinant technology, NUPLURA™ PH provides immunity within 10 days after vaccination, and is safe for calves as young as 28 days. A booster dose can be administered prior to periods of stress or elevated risk of exposure.
For more information, contact your herd health veterinarian, Novartis Animal Health representative or visit www.livestock.novartis.com.
Bimeda’s AmproMed™ FOR CALVES (amprolium) has received FDA approval as a calf coccidiostat. Available in a 20% soluble powder form, its indicated as an aid in the treatment and prevention of coccidiosis caused by Eimeria bovis and E. zurnii in calves by following either the five-day treatment protocol or 21-day prevention protocol. Available in 10-oz. packets, the powder form offers advantages of easier storage and handling, and more recyclability, compared to typical gallon containers.
For more information, call 888-524-6332 or visit www.bimeda.com.